---
title: AMOS CLINICAL RESEARCH KERNEL V0 SCIENCE HEALTH2
type: kernel
source: 11_KNOWLEDGE/kernel
canon-group: biology
canon-type: framework
rscf-state: source-claim
topic: amos-clinical-research-kernel-v0
tags:
- canon-group/biology
- canon/framework
- rscf/claim
- rscf/provenance
- rscf/state/source-claim
- topic/amos-clinical-research-kernel-v0
- kernel
- 00-cosmo-brain-moc
- kernel-moc
created: 2026-08-22
rscf:
  state: SOURCE_CLAIM
  claim_class: SOURCE_CLAIM
  provenance: AMOS_corpus
  scope: AMOS_knowledge
---

# AMOS_Clinical_Research_Kernel_v0

> [!info] Populated Stub
> Source: `AMOS_Clinical_Research_Kernel_v0_Biology_Cognition7_3.md` (vault-sourced, content_hash verified).
> Canon group: biology

## Status
- **Type**: Kernel spec
- **Content**: Vault-sourced from Biology_Cognition reference
- **Action**: Populated 2026-08-26 from source kernel

## Spec

```json
{
  "meta": {
    "name": "Clinical_Research_Kernel",
    "version": "1.0.0",
    "description": "Kernel for clinical research: trial design, conduct, analysis, and reporting."
  },
  "kernel": {
    "description": "Supports clinical research: trial design, protocol development, regulatory compliance, data collection, analysis, and reporting per CONSORT and other guidelines.",
    "functions": {
      "trial_design": {
        "description": "Design a clinical trial.",
        "inputs": ["research_question", "intervention", "population", "comparators", "primary_outcome", "regulatory_pathway"],
        "outputs": ["trial_design_summary", "phase_determination", "randomisation_scheme", "blinding_plan", "endpoint_selection"]
      },
      "protocol_development": {
        "description": "Develop a clinical trial protocol.",
        "inputs": ["trial_design", "ICH_GCP_requirements", "ethical_considerations", "statistical_plan", "operational_plan"],
        "outputs": ["protocol_document_outline", "informed_consent_requirements", "data_management_plan", "safety_monitoring_plan"]
      },
      "regulatory_compliance": {
        "description": "Check regulatory and ethical compliance.",
        "inputs": ["trial_details", "jurisdiction", "submission_pathway", "vulnerable_population_involvement"],
        "outputs": ["compliance_checklist", "IRB/ethics_requirements", "regulatory_submission_needs", "risk_based_monitoring_plan"]
      },
      "results_reporting": {
        "description": "Report trial results per CONSORT and other guidelines.",
        "inputs": ["trial_results", "consort_checklist", "subgroup_analyses", "adverse_events", "limitations"],
        "outputs": ["consort_flow_diagram_description", "results_summary", "adverse_event_summary", "interpretation_and_limitation"]
      }
    },
    "capabilities": {
      "trial_phases": "Phase I (safety), Phase II (dose-finding/efficacy signal), Phase III (confirmatory), Phase IV (post-market).",
      "design_types": "Parallel, crossover, factorial, cluster, adaptive, basket, umbrella.",
      "ethical_frameworks": "Declaration of Helsinki, ICH GCP E6(R2), CIOMS guidelines, Belmont Report principles.",
      "reporting_guidelines": "CONSORT, SPIRIT, PRISMA, STROBE, STARD, ICH E3.",
      "data_management": "Case report forms, data validation, SAE reporting, data monitoring committees."
    }
  }
}
```

## Related
- [[AMOS_MBB_CONSULTING_KERNEL_V0]]
- [[AMOS_MARKET_ECON_KERNEL_V0]]
- [[AMOS_OS_INTEGRATED_AGENT_KERNEL]]
- [[AMOS_POLICY_GEOSTRATEGY_KERNEL_V0]]
- RSCF-Brain-MOC
- [[00_COSMO_BRAIN_MOC]]
- AMOS_Clinical_Research_Kernel_v0_Biology_Cognition7_3 (source)

---
**MOC:** [[KERNEL_MOC]]

